In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureus

Staphylococcus aureus is an opportunistic pathogen and remains a common cause of burn wound infections. Different studies have shown that entrapment of plant-derived compounds into liposomes could increase their anti-Staphylococcus aureus activity. Silymarin is the bioactive extract from the known plant Silybum marianum L. The objective of this study was to evaluate efficacy of silymarin in free and nanoliposomal forms against isolated methicillin-resistant Staphylococcus aureus (MRSA) strain. Silymarin-loaded nanoliposomes were prepared by extrusion method. The minimum inhibitory concentrations (MICs) of silymarin in free and nanoliposomal forms against MRSA were determined by broth dilution method. The killing rate of free and nanoliposomal forms of silymarin were analyzed. Ultimately, in-vivo therapeutic efficacy of nanoliposomes in burned mice infected by isolated MRSA was examined. The MICs of free and nanoliposomal forms of silymarin against isolated strain were 500 and 125 mg/L, respectively. The killing rate of silymarin-loaded nanoliposomes was higher than those of free silymarin. Topically treatment by silymarin in free and nanoliposomal forms resulted in almost 20 and 100% survival rates, respectively. The results suggest that silymarin-loaded nanoliposomes may provide a basis for future treatment of MRSA infections.

[1]  M. Jaafari,et al.  Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer , 2014, Iranian journal of pharmaceutical research : IJPR.

[2]  Xiaoying Wang,et al.  Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy , 2013, International journal of nanomedicine.

[3]  S. Mortazavi,et al.  An Investigation into Some Effective Factors on Encapsulation Efficiency of Alpha-Tocopherol in MLVs and the Release Profile from the Corresponding Liposomal Gel , 2013, Iranian journal of pharmaceutical research : IJPR.

[4]  Xuming Deng,et al.  Silibinin In Vitro Protects A549 Cells from Staphylococcus aureus-Mediated Injury and In Vivo Alleviates the Lung Injury of Staphylococcal Pneumonia , 2013, Planta Medica.

[5]  Z. Faezizadeh,et al.  Therapeutic Efficacy of Epigallocatechin Gallate-Loaded Nanoliposomes against Burn Wound Infection by Methicillin-Resistant Staphylococcus aureus , 2012, Skin Pharmacology and Physiology.

[6]  Z. Faezizadeh,et al.  In Vitro and in Vivo Antibacterial Activities of Cyanidinum Chloride-loaded Liposomes against a Resistant Strain of Pseudomonas aeruginosa , 2012, Planta Medica.

[7]  A. Allameh,et al.  The Effect of Silymarin on Telomerase Activity in the Human Leukemia Cell Line K562 , 2012, Planta Medica.

[8]  Sanjun Shi,et al.  Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes , 2011, International journal of nanomedicine.

[9]  N. Ali,et al.  Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice , 2011, PloS one.

[10]  A. Azmi,et al.  Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents , 2011, Cancers.

[11]  J. C. Cardoso,et al.  Collagen-Based Films Containing Liposome-Loaded Usnic Acid as Dressing for Dermal Burn Healing , 2011, Journal of biomedicine & biotechnology.

[12]  Chun-Ming Huang,et al.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.

[13]  Michael R Hamblin,et al.  Topical antimicrobials for burn wound infections. , 2010, Recent patents on anti-infective drug discovery.

[14]  C. Kokare,et al.  Formulation and Evaluation of Topical Liposomal Gel for Fluconazole , 2010 .

[15]  A. Bafna,et al.  Evaluation of the wound healing activity of a crude extract of Rubia cordifolia L. (Indian madder) in mice , 2009 .

[16]  V. Dwivedi,et al.  In Vitro Microbial Efficacy of Sulbactomax: A Novel Fixed Dose Combination of Ceftriaxone Sulbactam and Ceftriaxone Alone , 2009 .

[17]  W. Elshemey,et al.  IN VITRO ANTIBACTERIAL ACTIVITY OF LIPOSOMAL CEPHALEXIN AGAINST STAPHYLOCOCCUS AUREUS , 2008 .

[18]  F. Vandenesch,et al.  Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo , 2007, The British journal of dermatology.

[19]  A. Seth,et al.  Preparation and Evaluation of Acyclovir Liposomes by Two Techniques: A Comparative Study , 2007 .

[20]  T. Hwang,et al.  Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. , 2006, International journal of pharmaceutics.

[21]  Tim Cushnie,et al.  Errata for “Antimicrobial activity of flavonoids” [Int. J. Antimicrob. Agents 26 (2005) 343–356] , 2006 .

[22]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[23]  G. Ridgway,et al.  Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). , 2005, The Journal of antimicrobial chemotherapy.

[24]  Andrew J Lamb,et al.  Antimicrobial activity of flavonoids , 2005, International Journal of Antimicrobial Agents.

[25]  C. Hung,et al.  Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations , 2005, Journal of drug targeting.

[26]  J. Wong,et al.  Therapeutic Efficacy of “Nubiotics” against Burn Wound Infection by Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[27]  G. Asghari,et al.  Biotransformation of Aromatic Aldehydes by Cell Cultures of Peganum harmala L. and Silybum marianum (L.) Gaertn , 2004 .

[28]  M. Schaller,et al.  Toxicity and Antimicrobial Activity of a Hydrocolloid Dressing Containing Silver Particles in an ex vivo Model of Cutaneous Infection , 2003, Skin Pharmacology and Physiology.

[29]  R. Ševčík,et al.  Analysis of the active components of silymarin. , 2003, Journal of chromatography. A.

[30]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[31]  C. Goodwin,et al.  Burn Wound Infections: Current Status , 1998, World Journal of Surgery.

[32]  D. Klein,et al.  Wound infection following trauma and burn injuries. , 1995, Critical care nursing clinics of North America.

[33]  B. Jovanovic,et al.  Nosocomial infections in a burn intensive care unit. , 1995, Burns : journal of the International Society for Burn Injuries.

[34]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[35]  A. Rowan.  Guide for the Care and Use of Laboratory Animals , 1979 .